Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C not responding to previous interferon alone.

被引：0
|
作者：
De Ledinghen, V
Trimoulet, P
Winnock, M
Bernard, PH
Bourliere, M
Portal, I
Remy, AJ
Canva, V
Levy, S
Foucher, J
Chene, G
Couzigou, P
机构：
[1] Hop Haut Leveque, Pessac, France
[2] INSERM, U330, Bordeaux, France
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1655
引用
收藏
页码：586A / 586A
页数：1
相关论文
共 50 条
  • [21] Pilot dose-finding trial on interferon alpha in combination with ribavirin for the treatment of chronic hepatitis C in patients not responding to interferon alone
    Puoti, M
    Cadeo, GP
    Putzolu, V
    Forleo, MA
    Barni, MC
    Cristini, G
    Rossi, S
    Spinetti, A
    Zaltron, S
    Zanini, B
    Quiros-Roldan, E
    Paraninfo, G
    Gargiulo, F
    Carosi, G
    DIGESTIVE AND LIVER DISEASE, 2001, 33 (02): : 163 - 172
  • [22] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    Rao, P. N.
    Koshy, Abraham
    Philip, Jacob
    Premaletha, Narayanan
    Varghese, Joy
    Narayanasamy, Krishnasamy
    Mohindra, Samir
    Pai, Nitin Vikas
    Agarwal, Manoj Kumar
    Konar, Ashoknanda
    Vora, Hasmukh B.
    WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (07) : 520 - 526
  • [23] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    PN Rao
    Abraham Koshy
    Jacob Philip
    Narayanan Premaletha
    Joy Varghese
    Krishnasamy Narayanasamy
    Samir Mohindra
    Nitin Vikas Pai
    Manoj Kumar Agarwal
    Ashokna Konar
    Hasmukh B Vora
    World Journal of Hepatology, 2014, (07) : 520 - 526
  • [24] Long term response to interferon and ribavirin for hepatitis C in patients previously treated with interferon alone.
    Ismail, MK
    Fleckenstein, JF
    Bockhold, K
    Waters, B
    Riely, CA
    HEPATOLOGY, 1999, 30 (04) : 636A - 636A
  • [25] Consensus Interferon and Ribavirin in Patients with Chronic Hepatitis C Who Were Nonresponders to Pegylated Interferon alfa-2b and Ribavirin
    Carroll B. Leevy
    Digestive Diseases and Sciences, 2008, 53 : 1961 - 1966
  • [26] Interferon alfa-2b and ribavirin in patients with resistant chronic hepatitis C.
    Min, AD
    Jones, JL
    Jacobson, IM
    Klion, FM
    Goldman, IS
    Esposito, S
    Geders, JM
    Tobias, H
    Bodenheimer, HC
    HEPATOLOGY, 1999, 30 (04) : 192A - 192A
  • [27] Consensus interferon and ribavirin in patients with chronic hepatitis c who were nonresponders to pegylated interferon alfa-2b and ribavirin
    Leevy, Carroll B.
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (07) : 1961 - 1966
  • [28] Consensus Interferon and Ribavirin in Patients with Chronic Hepatitis C Who Were Nonresponders to Pegylated Interferon alfa-2b and Ribavirin
    Carroll B. Leevy
    Digestive Diseases and Sciences, 2008, 53 (7) : 2009 - 2009
  • [29] Interferon alone or in combination with ribavirin for the treatment of chronic hepatitis C genotype IV
    Shiha, G
    Salem, S
    JOURNAL OF HEPATOLOGY, 2002, 36 : 129 - 129
  • [30] Treatment of chronic hepatitis C virus infection with α-interferon alone or in combination with ribavirin
    Marra, F
    Yoshida, EM
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1999, 8 (09) : 429 - 438
12345